Good Morning. Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from a selection of the world’s leading news organizations.Want this emailed directly to your inbox? Send us an email at contact@thewirechina.com to sign up.
The Wall Street Journal
Neurological Drugmaker BioShin Gets $60 Million to Tap Asia-Pacific Market — OrbiMed Advisors led the funding round for the Shanghai-based subsidiary of Biohaven Pharmaceutical, maker of Nurtec.Pentagon Can Help Beat China in 5G — Share its under-used spectrum so private businesses can use it commercially.Possible China Blacklist Adds More Uncertainty for U.S. Businesses — The division of the internet and technologies along national lines could weigh more heavily on smaller companies, which may find it difficult to compete in countries that prefer domestic competitors.
The Financial Times
Business must keep pushing for freedom in Hong
Subscribe or login to read the rest.
Subscribers get full access to:
- Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
- A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
- A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our
Subscriptions page for details.
